BREAKING NEWS: Moderna's COVID-19 vaccine is 90% effective at protecting against infection six months after the final doseNew data from the phase III clinical trial showed Moderna was 90% effective at preventing COVID-19 infection six months after the second doseThe shot was also more than 95% at preventing severe disease six months outThis brings Moderna one step closer to filing for full approval with the FDA after it was approved for emergency use in 2020
By Mary Kekatos Senior Health Reporter For Dailymail.com
Published: 16:50 EDT, 13 April 2021 | Updated: 16:50 EDT, 13 April 2021
Moderna Inc says its vaccine is more than 90 percent effective at protecting against COVID-19 six months after the second dose.
In updated data from its phase III clinical trial published on Tuesday, the company also said its jab is more than 95 percent effective against severe disease 24 weeks after receiving the final dose.
The new data brings Moderna closer to filing for full approval with the U.S. Food and Drug Administration (FDA)
The vaccine was approved for emergency use in those aged 18 and older in December 2020 but with just two months of safety data.
New data from the phase III clinical trial showed Moderna was 90% effective at preventing COVID-19 infection six months after the second dosePictured: A vial of Moderna's COVID-19 vaccine, April 7
This is a breaking news story and will be updated.